Companies will partner to advance small molecules in up to six discrete projects, including three existing programs against specific predetermined targets
US-based biotechnology company Exelixis has signed an exclusive collaboration, option and license agreement with India-based Aurigene Discovery Technologies for discovery and development of new oncology treatments.